ArticleHemaSphere2026

The case for targeting enhancer regions in high-risk TCF3::HLF-positive B-cell acute lymphoblastic leukemia.

Zahra Sheybani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.